ImmunityBio, Inc. IBRX EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s EPS (basic)?
- ImmunityBio, Inc. (IBRX) reported EPS (basic) of -$0.62 in Q1 2026.
- How has ImmunityBio, Inc.'s EPS (basic) changed year-over-year?
- ImmunityBio, Inc.'s EPS (basic) decreased by 313.3% year-over-year, from -$0.15 to -$0.62.
- What is the long-term trend for ImmunityBio, Inc.'s EPS (basic)?
- Over 4 years (2021 to 2025), ImmunityBio, Inc.'s EPS (basic) has grown at a -19.2% compound annual growth rate (CAGR), from -$0.89 to -$0.38.
- What does EPS (basic) mean?
- The portion of a company's profit allocated to each individual share of common stock.
- How do you interpret EPS (basic)?
- Higher values indicate better per-share profitability, while negative values indicate a loss per share.
- How does EPS (basic) compare across companies?
- Standardized metric for comparing earnings power across companies with different share counts.